Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 10,290 Oruka Therapeutics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 18, 2026

On May 18, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 10,290 Oruka Therapeutics, Inc. shares at an average US$59.07 for US$608K under a trading plan, leaving 16,406 shares. Filed May 18, 2026 (Form 4).

Sold: 10,290 shares
Price: US$59.07 average (US$58.34 to US$61.16)
Value: US$608K
Holding after: 16,406 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Senior Vice President, Finance

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 18, 2026	Common Stock	Option exercise	2,000	US$12.50	20,863	Direct
May 18, 2026	Common Stock	Option exercise	5,833	US$34.39	26,696	Direct
May 18, 2026	Common Stock	Sale	4,190	US$58.34	22,506	Direct
May 18, 2026	Common Stock	Sale	4,600	US$59.19	17,906	Direct
May 18, 2026	Common Stock	Sale	800	US$60.34	17,106	Direct
May 18, 2026	Common Stock	Sale	700	US$61.16	16,406	Direct

Source

View original at SEC

Related